Masimo Corp (MASI)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

52 DISCOVERY IRVINE, CA 92618

Masimo Corporation engages in the development, licensing, and marketing of advanced signal processing technologies and products for the noninvasive monitoring of vital signs. The company licenses its Masimo Signal Extraction Technology pulse oximetry, Masimo SET, to approximately 35 international patient monitoring systems providers.

Data as of 2020-10-17
Market Cap13.039 Billion Shares Outstanding54.948 Million Avg 30-day Volume385.514 Thousand
P/E Ratio60.1 Dividend Yield EPS3.87
Price/Sales15.939 Price cash flow ratio59.1 Price free cash flow ratio442.1
Book Value24.47 Price to Tangible Book10.58 Alpha0.03
Short Interest Ratio % Short Interest to Float R-squared0.186372
BETA0.787675 52-week High/Low258.0 / 140.53 Stddev0.078358
View SEC Filings from MASI instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 6 8 -25.0% 1 (0.07%) 2 (0.13%) -50.0%
Funds Holding: 463 395 17.22% 98 (6.39%) 92 (5.88%) 6.52%
13F shares: 45.25 Million 45.751 Million -1.1% 9.037 Million 10.571 Million -14.51%
% Ownership 82.3505 84.5439 -2.59% 16.4469 19.5349 -15.81%
New Positions: 118 60 96.67% 25 14 78.57%
Increased Positions 156 115 35.65% 25 20 25.0%
Closed Positions 44 41 7.32% 17 10 70.0%
Reduced Positions 142 157 -9.55% 43 48 -10.42%
Total Calls 310.982 Thousand 133.504 Thousand 132.94% 54.7 Thousand 25.3 Thousand 116.21%
Total Puts 159.122 Thousand 64.944 Thousand 145.01% 48.25 Thousand 15.1 Thousand 219.54%
PUT/CALL Ratio 0.51 0.49 4.08% 0.88 0.6 46.67%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MASI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MASI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

127.5 Thousand total shares from 8 transactions

Exercise Derivative Conversion (M)

127.5 Thousand total shares from 8 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

YOUNG MICAH W EVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2020-10-19 4

REYNOLDS CRAIG B

  • Director
4,300 2020-10-12 3

LEE YONGSAM EVP, CIO

  • Officer
75,000 2020-10-07 6

KIANI JOE E CEO AND CHAIRMAN OF THE BOARD

  • Officer
  • Director
3,920,109 2020-10-07 9

MCCLENAHAN THOMAS SAMUEL EVP, GEN COUNSEL & CORP SEC

  • Officer
6,264 2020-10-07 7

MUHSIN BILAL CHIEF OPERATING OFFICER

  • Officer
0 2020-10-07 4

COLEMAN JON PRES-WW SALES,PRO SVC,MED AFFS

  • Officer
12,465 2020-07-06 4

MIKKELSON ADAM

  • Director
2,802 2020-06-08 2

COHEN H MICHAEL

  • Director
717 2020-06-04 2

BARKER STEVEN

  • Director
67,549 2020-05-29 3

FITCH SANFORD

  • Director
54,522 2020-05-29 4

HARKIN THOMAS

  • Director
7,685 2020-05-29 1

SHIMER JULIE ANN

  • Director
1,304 2020-05-29 1

VAN RAMSHORST DAVID J SVP, CHIEF ACCOUNTING OFFICER

  • Officer
1,000 2020-04-14 4

SAMPATH ANAND EVP, OPS & CLINICAL RESEARCH

  • Officer
13,782 2020-04-13 4

LEVY TAO EVP, BUS DEV

  • Officer
0 2020-03-12 1

FISHEL RICK PRES, WW OEM BUSINESS...

  • Officer
20,022 2017-07-14 0

DE RAAD MARK EVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2017-06-05 0

LECLERCQ THIERRY EVP, BUS DEV

  • Officer
0 2017-05-08 0

JANSEN PAUL EVP, BUS DEV

  • Officer
6,389 2017-03-08 0

LASERSOHN JACK W

  • Director
0 2015-12-17 0

CAHILL EDWARD L

  • Director
0 2014-02-18 0

COLEMAN ROBERT

  • Director
0 2014-02-18 0

ALLAN ANTHONY CHIEF OPERATING OFFICER

  • Officer
10,524 2011-11-21 0

PAUL STEPHEN E. EVP, ACUTE CARE SALES

  • Officer
6,000 2011-05-02 0

O'REILLY MICHAEL CHIEF MEDICAL OFFICER

  • Officer
0 2011-02-22 0

AL-ALI AMMAR

  • CHIEF ENGINEER
No longer subject to file 2010-02-11 0

CAMPBELL BRIAN

  • VP, OPERATIONS
0 2009-10-05 0

GOODMAN DAVID EVP, BUSINESS DEVELOPMENT

  • Officer
0 2008-09-15 0

MORAN STEPHEN M EVP, GENERAL COUNSEL

  • Officer
0 2008-07-14 0

BERTHON OLIVIER PRESIDENT, MASIMO EUROPE

  • Officer
74,250 2008-05-14 0

MANIWA TETSURO PRESIDENT, MASIMO JAPAN

  • Officer
0 2008-05-02 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

YOUNG MICAH W - Officer EVP & CHIEF FINANCIAL OFFICER

2020-10-21 17:09:02 -0400 2020-10-19 M 10,000 $84.97 d 20,000 direct

YOUNG MICAH W - Officer EVP & CHIEF FINANCIAL OFFICER

2020-10-21 17:09:02 -0400 2020-10-19 S 10,000 $239.00 d 0 direct yes

YOUNG MICAH W - Officer EVP & CHIEF FINANCIAL OFFICER

2020-10-21 17:09:02 -0400 2020-10-19 M 10,000 $84.97 a 10,000 direct

REYNOLDS CRAIG B - Director

2020-10-14 16:14:37 -0400 2020-10-12 M 10,000 $23.04 d 70,000 direct

REYNOLDS CRAIG B - Director

2020-10-14 16:14:37 -0400 2020-10-12 M 10,000 $23.04 a 14,300 direct 1.9549 1.9549 2 0.0 1

REYNOLDS CRAIG B - Director

2020-10-14 16:14:37 -0400 2020-10-12 M 10,000 $23.04 d 80,000 direct

REYNOLDS CRAIG B - Director

2020-10-14 16:14:37 -0400 2020-10-12 S 10,000 $239.34 d 4,300 direct yes 1.9549 1.9549 2 0.0 1

REYNOLDS CRAIG B - Director

2020-10-14 16:14:37 -0400 2020-10-12 S 10,000 $240.87 d 4,300 direct yes 1.9549 1.9549 2 0.0 1

REYNOLDS CRAIG B - Director

2020-10-14 16:14:37 -0400 2020-10-12 M 10,000 $23.04 a 14,300 direct 1.9549 1.9549 2 0.0 1

MUHSIN BILAL - Officer CHIEF OPERATING OFFICER

2020-10-09 16:08:48 -0400 2020-10-07 M 25,000 $34.51 a 25,000 direct -0.0086 1.2716 1.9417 5 -0.3823 3

LEE YONGSAM - Officer EVP, CIO

2020-10-09 16:10:43 -0400 2020-10-07 M 10,000 $37.84 d 16,000 direct

MCCLENAHAN THOMAS SAMUEL - Officer EVP, GEN COUNSEL & CORP SEC

2020-10-09 16:13:17 -0400 2020-10-07 M 5,000 $31.01 d 19,000 direct

MCCLENAHAN THOMAS SAMUEL - Officer EVP, GEN COUNSEL & CORP SEC

2020-10-09 16:13:17 -0400 2020-10-07 M 5,000 $31.01 a 11,264 direct -0.0086 1.2716 1.9417 5 -0.3823 3

KIANI JOE E - Director - Officer CEO AND CHAIRMAN OF THE BOARD

2020-10-09 16:17:31 -0400 2020-10-07 M 52,492 $28.03 d 247,508 direct

MUHSIN BILAL - Officer CHIEF OPERATING OFFICER

2020-10-09 16:08:48 -0400 2020-10-07 M 25,000 $34.51 d 10,000 direct

LEE YONGSAM - Officer EVP, CIO

2020-10-09 16:10:43 -0400 2020-10-07 S 10,000 $250.00 d 75,000 direct yes -0.0086 1.2716 1.9417 5 -0.3823 3

MCCLENAHAN THOMAS SAMUEL - Officer EVP, GEN COUNSEL & CORP SEC

2020-10-09 16:13:17 -0400 2020-10-07 M 5,000 $28.03 d 0 direct

MCCLENAHAN THOMAS SAMUEL - Officer EVP, GEN COUNSEL & CORP SEC

2020-10-09 16:13:17 -0400 2020-10-07 S 5,000 $254.00 d 6,264 direct yes -0.0086 1.2716 1.9417 5 -0.3823 3

KIANI JOE E - Director - Officer CEO AND CHAIRMAN OF THE BOARD

2020-10-09 16:17:31 -0400 2020-10-07 S 52,492 $250.87 d 159,241 direct yes -0.0086 1.2716 1.9417 5 -0.3823 3

MUHSIN BILAL - Officer CHIEF OPERATING OFFICER

2020-10-09 16:08:48 -0400 2020-10-07 S 25,000 $251.00 d 0 direct yes -0.0086 1.2716 1.9417 5 -0.3823 3

LEE YONGSAM - Officer EVP, CIO

2020-10-09 16:10:43 -0400 2020-10-07 M 10,000 $37.84 a 85,000 direct -0.0086 1.2716 1.9417 5 -0.3823 3

MCCLENAHAN THOMAS SAMUEL - Officer EVP, GEN COUNSEL & CORP SEC

2020-10-09 16:13:17 -0400 2020-10-07 S 5,000 $254.00 d 6,264 direct yes -0.0086 1.2716 1.9417 5 -0.3823 3

MCCLENAHAN THOMAS SAMUEL - Officer EVP, GEN COUNSEL & CORP SEC

2020-10-09 16:13:17 -0400 2020-10-07 M 5,000 $28.03 a 11,264 direct -0.0086 1.2716 1.9417 5 -0.3823 3

KIANI JOE E - Director - Officer CEO AND CHAIRMAN OF THE BOARD

2020-10-09 16:17:31 -0400 2020-10-07 M 52,492 $28.03 a 211,733 direct -0.0086 1.2716 1.9417 5 -0.3823 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments